Abstract
The ability to provide susceptibility data for certain species of mycobacteria can be clinically useful. In this study, the disk elution method for susceptibility testing was adapted for testing ciprofloxacin against mycobacterial isolates. Of the 75 Mycobacterium tuberculosis isolates tested, including 23 multiply drug-resistant isolates, 96% were susceptible to ciprofloxacin at a breakpoint concentration of 2 micrograms/ml.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Babinchak T. J., Fass R. J. In vitro activity of DNA gyrase inhibitors, singly and in combination, against Mycobacterium avium complex. Diagn Microbiol Infect Dis. 1992 May-Jun;15(4):367–370. doi: 10.1016/0732-8893(92)90026-p. [DOI] [PubMed] [Google Scholar]
- Benson C. A., Kessler H. A., Pottage J. C., Jr, Trenholme G. M. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch Intern Med. 1991 Mar;151(3):582–585. [PubMed] [Google Scholar]
- CANETTI G., FROMAN S., GROSSET J., HAUDUROY P., LANGEROVA M., MAHLER H. T., MEISSNER G., MITCHISON D. A., SULA L. MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE. Bull World Health Organ. 1963;29:565–578. [PMC free article] [PubMed] [Google Scholar]
- Chiu J., Nussbaum J., Bozzette S., Tilles J. G., Young L. S., Leedom J., Heseltine P. N., McCutchan J. A. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group. Ann Intern Med. 1990 Sep 1;113(5):358–361. doi: 10.7326/0003-4819-113-5-358. [DOI] [PubMed] [Google Scholar]
- Fenlon C. H., Cynamon M. H. Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare. Antimicrob Agents Chemother. 1986 Mar;29(3):386–388. doi: 10.1128/aac.29.3.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horsburgh C. R., Jr, Mason U. G., 3rd, Heifets L. B., Southwick K., Labrecque J., Iseman M. D. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing. Am Rev Respir Dis. 1987 Feb;135(2):418–421. doi: 10.1164/arrd.1987.135.2.418. [DOI] [PubMed] [Google Scholar]
- Hussey G., Kibel M., Parker N. Ciprofloxacin treatment of multiply drug-resistant extrapulmonary tuberculosis in a child. Pediatr Infect Dis J. 1992 May;11(5):408–409. [PubMed] [Google Scholar]
- Kent R. J., Bakhtiar M., Shanson D. C. The in-vitro bactericidal activities of combinations of antimicrobial agents against clinical isolates of Mycobacterium avium-intracellulare. J Antimicrob Chemother. 1992 Nov;30(5):643–650. doi: 10.1093/jac/30.5.643. [DOI] [PubMed] [Google Scholar]
- Leysen D. C., Haemers A., Pattyn S. R. Mycobacteria and the new quinolones. Antimicrob Agents Chemother. 1989 Jan;33(1):1–5. doi: 10.1128/aac.33.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piersimoni C., Morbiducci V., Bornigia S., De Sio G., Scalise G. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis. Am Rev Respir Dis. 1992 Dec;146(6):1445–1447. doi: 10.1164/ajrccm/146.6.1445. [DOI] [PubMed] [Google Scholar]
- Tsukamura M. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex. Am Rev Respir Dis. 1988 Jan;137(1):144–148. doi: 10.1164/ajrccm/137.1.144. [DOI] [PubMed] [Google Scholar]